Not applicableUnknownNCT04686149
What this trial is testing
A Genome-based Platform to Predict Patients That Can Achieve Bladder Preservation in Muscle Invasive Bladder Cancer Patients
Who this might be right for
Muscle-Invasive Bladder Carcinoma
Yonsei University 39